Clinical Trial: Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Phase IV - Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application
Brief Summary: The main goal of this present study is evaluate the decreasing of necessity of topic corticoids usage to control outbreaks of light to moderate atopic dermatitis by using the correct emollients.
Detailed Summary:
Sponsor: Galderma Brasil Ltda.
Current Primary Outcome: clinical evaluation [ Time Frame: Baseline, Weeks 2, 4, 6, 8, 10, 12, 16, 20 and 24 ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Galderma Brasil Ltda.
Dates:
Date Received: February 4, 2010
Date Started: December 2009
Date Completion:
Last Updated: March 9, 2012
Last Verified: March 2012